granulomatosis with polyangiitis

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:disease
gptkbp:affects gptkb:Skin
kidneys
lungs
joints
blood vessels
eyes
upper respiratory tract
gptkbp:associated_with ANCA antibodies
gptkbp:autoimmune gptkb:true
gptkbp:cause gptkb:multiple_sclerosis
inflammation
gptkbp:complication hearing loss
lung damage
skin lesions
nerve damage
kidney failure
gptkbp:condition gptkb:microscopic_polyangiitis
gptkb:Churg-Strauss_syndrome
gptkb:Wegener's_granulomatosis
gptkbp:diagnosis CT scan
variable
blood tests
biopsy
depends on severity
depends on treatment
gptkbp:first_described_by 1950s
gptkbp:gender more common in males
https://www.w3.org/2000/01/rdf-schema#label granulomatosis with polyangiitis
gptkbp:inflammatory gptkb:true
gptkbp:is_monitored_by regular follow-ups
lung function tests
kidney function tests
ANCA levels
gptkbp:named_after gptkb:Friedrich_Wegener
gptkbp:premiered_on adulthood
gptkbp:prevalence rare
gptkbp:research ongoing
gptkbp:risk_factor smoking
genetic predisposition
infections
environmental exposures
gptkbp:scientific_classification small vessel vasculitis
gptkbp:symptoms fatigue
cough
sinusitis
hematuria
gptkbp:treatment gptkb:methotrexate
gptkb:cyclophosphamide
gptkb:rituximab
gptkb:azathioprine
corticosteroids
plasma exchange
immunosuppressants
gptkbp:bfsParent gptkb:Rituximab
gptkb:Rituxan
gptkbp:bfsLayer 5